Accessibility: Skip TopNav
CB-011 Immune Cloaking
CB-011 is engineered to improve persistence of antitumor response through an immune cloaking genome-editing approach that removes the B2M protein and inserts a B2M–HLA-E fusion protein.
Format
PNG
Source
Caribou Biosciences, Inc.
Downloads
Original
Large
Medium
Small